Notification: Get ready for our latest article!


Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART’ authored by Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens and Graeme Meintjes is on its way. Stay tuned for thought-provoking insights and valuable information coming your way 26 April 2024! Contribution excerpt: ‘This study supports switching to TLD as a third-line regimen or an alternative second-line regimen after PI regimen failure in a programmatic setting, with the caveat that patients switched to TLD in our study had no tenofovir resistance.'

Posted: 2024-04-22

Advertisement: CPD for Healthcare Professionals

CPD courses accredited by the HPCSA, HPCNA, and AHPCSA. The HPCSA and HPCNA have accepted the principle of cross recognition of CEUs. Visit AOSIS eCPD to earn your CEU points.  
Posted: 2022-01-28

Press Release: Online Resource & News Portal - Department of Health, Republic of South Africa

Visit for up to date information about the COVID-19 Pandemic. Hotline: 0800 029 999 | WhatsApp: 0600-123456  
Posted: 2022-01-28
1 - 3 of 3 Items